Education
About Us
Working with TipRanks
Follow Us
Siga Technologies (SIGA)
:SIGA
SIGA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.95 - $12.83
Previous CloseN/A
Volume59.56K
Average Volume (3M)535.15K
Market Cap
$427.91M
Enterprise Value$275.09M
Total Cash (Recent Filing)$8.51M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)7.2
Beta0.96
Next Earnings
May 01, 2025EPS EstimateN/A
Next Dividend Ex-Date
Apr 29, 2025Dividend Yield10.13%
Share Statistics
EPS (TTM)0.83
Shares Outstanding71,436,930
10 Day Avg. Volume730,463
30 Day Avg. Volume535,150
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.89
Price to Cash Flow (P/CF)1.80
P/FCF Ratio1.80
Enterprise Value/Market Cap0.64
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.98
Enterprise Value/Ebitda3.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
SIGA Technologies News
PremiumCompany Announcements
SIGA Technologies Appoints Gen. Keane as New Director
PremiumCompany Announcements
SIGA Technologies Reports Strong Financial Growth and Strategic Progress
PremiumCompany Announcements
SIGA Technologies Reports Strong 2024 Financial Performance
---
Ownership Overview
1.39% Insiders
14.09% Mutual Funds
0.31% Other Institutional Investors
74.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SIGA FAQ
What was Siga Technologies’s price range in the past 12 months?
Siga Technologies lowest stock price was $4.95 and its highest was $12.83 in the past 12 months.
What is Siga Technologies’s market cap?
Siga Technologies’s market cap is $427.91M.
When is Siga Technologies’s upcoming earnings report date?
Siga Technologies’s upcoming earnings report date is May 01, 2025 which is in 10 days.
How were Siga Technologies’s earnings last quarter?
Siga Technologies released its earnings results on Mar 11, 2025. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of N/A by $0.63.
Is Siga Technologies overvalued?
According to Wall Street analysts Siga Technologies’s price is currently Overvalued.
Does Siga Technologies pay dividends?
Siga Technologies pays a Annually dividend of $0.6 which represents an annual dividend yield of 10.13%. See more information on Siga Technologies dividends here
What is Siga Technologies’s EPS estimate?
Siga Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Siga Technologies have?
Siga Technologies has 71,436,930 shares outstanding.
What happened to Siga Technologies’s price movement after its last earnings report?
Siga Technologies reported an EPS of $0.63 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.964%.
Which hedge fund is a major shareholder of Siga Technologies?
Currently, no hedge funds are holding shares in SIGA
---
SIGA Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
SIGA Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 9.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.61%
12-Months-Change
Fundamentals
Return on Equity
28.70%
Trailing 12-Months
Asset Growth
-3.92%
Trailing 12-Months
Company Description
Siga Technologies
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
---
SIGA Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
SIGA had a year of strong financial performance and strategic progress, with notable sales growth and international expansion. Challenges with mpox clinical trials were addressed, but they did not significantly dampen the overall positive trajectory. The company's strong cash position and strategic partnerships provide a solid foundation for future growth.Read More>---
Technical Analysis
Emergent Biosolutions
―
Evotec AG
―
Organogenesis Holdings
―
Aquestive Therapeutics
―
Regencell Bioscience
―
---